U.S. Government Secures 3.2 Million Doses of Novavax COVID-19 ... - 11 July 2022 22:10

GAITHERSBURG, Md., July 11, 2022 /PRNewswire-Asianet/ -- --Agreement will provide the first protein-based vaccine option in the U.S., pending FDA Emergency Use Authorization and CDC recommendation Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing ...

  A new study confirms: EMDR therapy can be done effectively onl... - 08 July 2022 09:01

WORCESTER, England, July 7, 2022 /PRNewswireAsiaNet/ -- A first of its kind academic research confirms that conducting online EMDR therapy using remotEMDR, the world's leading platform for online EMDR therapy, is safe, effective, efficient, and relevant. Watch remotEMDR's video to find out more. ...

  harrison.ai and Sonic Healthcare join forces to launch 'frankl... - 06 July 2022 12:34

SYDNEY, July 6, 2022 /PRNewswire-AsiaNet/ -- franklin.ai aims to apply the latest methodologies in artificial intelligence (AI) to put groundbreaking AI tools into the hands of pathologists. harrison.ai(https://harrison.ai/), the clinically led healthcare AI platform and Sonic Healthcare(...

  Zsquare receives FDA Clearance to Market for First High-Perfor... - 06 July 2022 10:00

TEL AVIV, Israel, July 6, 2022 /PRNewswire-AsiaNet/ -- - Company's patented polymeric fiber is a breakthrough in the world of miniaturizing visualization - Zsquare ENT-Flex(TM) Rhinolaryngoscope advances the ENT category with a best-in-class 2.3mm outer diameter for high-resolution image quality at...

  NHS Scotland awards national laboratory medicine framework to ... - 05 July 2022 17:38

EDINBURGH, Scotland, July 5, 2022 /PRNewswire-AsiaNet/ -- Scotland is on its way to becoming home to the UK's largest connected laboratory medicine network, following the appointment of Citadel Health ( https://citadelhealth.co.uk/nhs-scotland-awards-national-laboratory-medicine-framework-to-citadel-heal...

  EditForce and Mitsubishi Tanabe Pharma Enter into License Agre... - 05 July 2022 17:00

FUKUOKA, Japan, July 5, 2022 /Kyodo JBN-AsiaNet/ -- EditForce, Inc. (Headquarters: Fukuoka, President and CEO: Takashi Ono; hereinafter "EditForce") has entered into a License Agreement (hereinafter "Agreement") with Mitsubishi Tanabe Pharma Corporation (Headquarters: Osaka, Representative Director...

  Octapharma shares new data at ISTH 2022 in its mission to meet... - 04 July 2022 20:00

LACHEN, Switzerland, July 4, 2022 /PRNewswire-AsiaNet/-- - Octapharma to present new clinical and scientific data from across Octapharma's haematology and critical care portfolios during the ISTH 2022 Congress - Data to be presented in 11 poster presentations and during two Supported Symposia - New da...

  Neuromod Publishes Results of Second Large Scale Clinical Tria... - 30 June 2022 21:00

DUBLIN, June 30, 2022 /PRNewswire-AsiaNet/ -- - Second large-scale trial shows greater reduction in tinnitus symptom severity using bimodal neuromodulation device, Lenire(R) - 91% of treatment compliant participants experienced improvement in tinnitus symptoms that sustained 12 months after ...

  New biomarkers unlock potential for more effective treatment o... - 30 June 2022 01:21

MADRID, June 29, 2022 /PRNewswire-AsiaNet/ -- - A new study focused on decoding the genetic chaos found in cancer cells is on the cover of the June issue of the scientific journal Nature. - This work reveals novel biomarkers with the potential to improve the development of precision therap...

  Tarkus, the Colombian phyto-therapeutic laboratory that is con... - 29 June 2022 09:51

BOGOTA, Colombia, June 29, 2022 /PRNewswire-AsiaNet/ -- -- Tarkus Pharma Lab, the first pharmaceutical laboratory located in a Free Trade Zone in Colombia, has become a global industry benchmark, developing raw materials and final products derived from medical cannabis with the highest quality, and exp...